Skip to content

Mannkind MNKD Net debt / EBITDA

Net debt / EBITDA at other companies

Eli Lilly logo
Eli LillyLLY
1.1×-1.1×
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
-1.9×
Merit Medical Systems logo
Merit Medical SystemsMMSI
1.1×-0.5×
Abbott logo
AbbottABT
2.5×+1.9×
AdaptHealth logo
AdaptHealthAHCO
4.7×+1.3×
Boston Scientific logo
Boston ScientificBSX
-0.1×-2.9×

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.32B+14.9%
Enterprise value$1.28B+15.8%
P/E253.5×
P/S3.7×-0.1×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Calculated from Mannkind’s reported figures.

Based on the most recent quarter.

The official record: Mannkind’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's net debt / EBITDA?
Mannkind (MNKD) reported net debt / EBITDA of -1.4× in Q3 2025.
How has Mannkind's net debt / EBITDA changed year-over-year?
Mannkind's net debt / EBITDA decreased by 79.7% year-over-year, from -0.8× to -1.4×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.